243,556 Shares in Danaher Corporation $DHR Acquired by Public Employees Retirement System of Ohio

Public Employees Retirement System of Ohio purchased a new stake in shares of Danaher Corporation (NYSE:DHR) in the second quarter, Holdings Channel reports. The firm purchased 243,556 shares of the conglomerate’s stock, valued at approximately $46,393,000.

A number of other large investors have also recently made changes to their positions in the business. BlackRock Inc. purchased a new stake in shares of Danaher in the second quarter valued at about $10,492,520,000. State Street Corp grew its position in Danaher by 1.7% in the 4th quarter. State Street Corp now owns 27,681,334 shares of the conglomerate’s stock worth $6,345,529,000 after purchasing an additional 472,608 shares in the last quarter. Capital International Investors increased its stake in Danaher by 8.9% in the 4th quarter. Capital International Investors now owns 18,246,008 shares of the conglomerate’s stock valued at $4,177,386,000 after buying an additional 1,487,768 shares during the last quarter. Price T Rowe Associates Inc. MD lifted its position in shares of Danaher by 9.1% during the 4th quarter. Price T Rowe Associates Inc. MD now owns 15,973,240 shares of the conglomerate’s stock worth $3,656,595,000 after buying an additional 1,334,221 shares in the last quarter. Finally, Wellington Management Group LLP lifted its position in shares of Danaher by 11.2% during the 4th quarter. Wellington Management Group LLP now owns 15,076,796 shares of the conglomerate’s stock worth $3,451,380,000 after buying an additional 1,517,904 shares in the last quarter. 79.05% of the stock is owned by institutional investors.

Danaher Stock Performance

Shares of DHR stock opened at $215.74 on Friday. The firm has a market capitalization of $151.67 billion, a PE ratio of 38.32, a P/E/G ratio of 2.68 and a beta of 0.78. The company has a 50 day moving average price of $198.69 and a 200-day moving average price of $192.35. Danaher Corporation has a 52 week low of $160.93 and a 52 week high of $242.80. The company has a quick ratio of 1.25, a current ratio of 1.65 and a debt-to-equity ratio of 0.48.

Danaher (NYSE:DHR) last released its quarterly earnings results on Monday, July 20th. The conglomerate reported $1.94 EPS for the quarter, beating the consensus estimate of $1.85 by $0.09. The firm had revenue of $6.26 billion during the quarter, compared to analyst estimates of $6.12 billion. Danaher had a net margin of 15.95% and a return on equity of 11.04%. The business’s revenue for the quarter was up 5.5% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $0.77 EPS. As a group, equities research analysts expect that Danaher Corporation will post 8.53 earnings per share for the current year.

Wall Street Analysts Forecast Growth

Several research analysts have weighed in on the company. Citigroup assumed coverage on Danaher in a research report on Tuesday, May 26th. They issued a “buy” rating and a $230.00 price objective on the stock. Piper Sandler began coverage on Danaher in a research note on Thursday, June 11th. They set a “neutral” rating and a $200.00 target price on the stock. Deutsche Bank Aktiengesellschaft restated a “buy” rating and set a $240.00 price target on shares of Danaher in a research report on Wednesday, July 22nd. Wolfe Research downgraded shares of Danaher from an “outperform” rating to a “peer perform” rating in a report on Monday, June 1st. Finally, Weiss Ratings raised shares of Danaher from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Wednesday, July 15th. One analyst has rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating and five have assigned a Hold rating to the stock. According to data from MarketBeat.com, Danaher currently has a consensus rating of “Moderate Buy” and an average target price of $228.91.

About Danaher

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.